Establishment and characterization of a human glioblastoma multiforme cell line

Cancer Genetics and Cytogenetics

Volumn 103, Issue 1, 1998, Pages 46-51

  Bakir, Abdurrahman ^a   Gezen, Ferruh ^a   Yildiz, Oguzhan ^a   Ayhan, Ayse ^b   Kahraman, Serdar ^a   Kruse, Carol A ^c   Varella Garcia, Marileila ^d   Yildiz, Ferah ^b   Kubar, Ayhan ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

^c UNIVERSITY OF COLORADO   (United States)

^d UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BRAIN TUMOR; CASE REPORT; CENTRAL NERVOUS SYSTEM TUMOR; GLIOBLASTOMA; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; KARYOTYPE; MALE; PRIORITY JOURNAL; TUMOR CELL CULTURE; TUMOR GROWTH;

AGED; AGED, 80 AND OVER; CELL CULTURE TECHNIQUES; CELL DIVISION; GLIOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; KARYOTYPING; MALE; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY;

EID: 0032077294     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(97)00364-6     Document Type: Article

References (38)

1. Bigner DD, Bigner SH, Pont NJ, Westermark B, Mahaley MS, Ruoslahti E, Herschman H, Eng LF, Wikstrand CJ (1981): Heterogeneity of genotypic and phenotypic characteristics of fifteen permanent cell lines derived from human gliomas. J Neuropathol Exp Neurol 40:201-229.
2. Chausy C, Delpech B, Olivier A, Bastard C, Girarad N, Courrel MN, Maingonnat C, Fråbourg T, Tayot J, Creissard P (1992): Establishment and characterization of a human glioma cell line. Eur J Cancer 28A:1129-1134.
3. Gjerset RA, Fakhrai H, Shawler DL, Turla S, Dorigo O, Grover-Bardwick A, Mercola D, Wen SF, Collins H, Lin H, Varella-Garcia M, Kruse CA, Royston I, Sobol RE (1995): Characterization of a new human glioblastoma cell line that expresses mutant p53 and lacks activation of PDGF pathway. In Vitro Cell Dev Biol 31:207-214.
4. Kruse CA, Mitchell DH, Kleinschmidt-DeMasters BK, Franklin WA, Morse HG, Spector EB, Lillehei KO (1992): Characterization of a continuous human glioma cell line dbtrg05mg: growth kinetics, karyotype, receptor expression, and tumor supressor gene analyses. In Vitro Cell Dev Biol 28A:609-614.
5. Pontén J, Maclntyre EH (1968): Long term culture of normal and neoplastic human glia. Acta Pathol Microbiol Scand 74:465-486.
6. Studer A, de Tribolet N, Diserens AC, Gaide AC, Matthieu JM, Carrel S, Stavrou D (1985): Characterization of four human malignant glioma cell lines. Acta Neuropathol (Berlin) 66:208-217.
7. Takeshita L, Sawa H (1990): Contrary effect of lactic acid on expression of neuron-specific enolase and glial fibrillary acidic protein in human glioma cells. Acta Neuropathologica 74:506-512.
8. Burger PC (1986): Malignant astrocytic neoplasms: classification, pathologic anatomy, and response to treatment. Sem Oncol 13:16-26.
9. Seabright M (1971): Rapid banding technique for human chromosomes. Lancet 2:971.
10. ISCN (1995): An International System for Human Cytogenetic Nomenclature. F Mitelman, ed. S. Karger, Basel.
11. Ayhan A, Yasui W, Yokozaki H, Ito H, Thara E (1992): Genetic abnormalities and expression of p53 in human colon carcinomas. Int J Oncology 1:431-437.
12. Bacciocchi G, Gibelli N, Zibera C, Pedrazolli P, Bergamaschi G, Polver PDP, Danova M, Mazzini G, Palomba L, Tupler R, Cuna GRD (1992): Establishment and characterization of two cell lines derived from human glioblastoma multiforme. Anticancer Res 12:853-862.
13. Dahl D, Ruegger DC, Bigmami A (1981): Vimentin, the 57000 molecular weight of fibroblast filaments, is major cytoskeletal component in immature glia. Eur J Cell Biol 24:191-196.
14. Bigner SH, Mark J, Bigner DD (1990): Cytogenetics of human brain tumors. Cancer Genet Cytogenet 47:141-154.
15. Heim S, Mitelman F (1995): Cancer Cytogenetics. ed 2, Wiley-Liss, New York, pp. 432-437.
16. Rasheed BK, McLendon RE, Herndon CE, Friedman HS, Friedman AH, Bigner DD, Bigner SH (1994): Alteration of the TP53 gene in human gliomas. Cancer Res 54:1324-1330.
17. Rey JA, Bello MJ, de Campos JM, Kusak ME, Ramos C, Benitez J (1987): Chromosomal patterns in human malignant astrocytomas. Cancer Genet Cytogenet 29:201-221.
18. Bigner SH, Mark J, Burger PC, Mahaley MS, Bullard DE, Muhlbaier LH, Bigner DD (1988): Specific chromosomal abnormalities in malignant human gliomas. Cancer Res 88:405-411.
19. Bello MJ, de Campos JM, Kusak ME, Vaquero J, Sarasa JL, Pestana A, Rey JA (1994): Molecular and cytogenetic analysis of chromosome 9 deletions in 75 malignant gliomas. Genes Chromosom Cancer 9:33-41.
20. Li YJ, Hoang-Xuan K, Delattre JY, Posioon M, Thomas G, Hamelin R (1995): Frequent loss of heterozygosity on chromosome 9 and low incidence of mutations of cyclin-dependent kinase inhibitors p15 (MTS2) and p16 (MTS1) genes in gliomas. Oncogene 11:597-600.
21. Sonoda Y, Yoshimoto T, Sekyia T (1995): Homozygous deletion of the MTS1/p16 and MTS2/p15 genes and amplification of the CDK4 gene in glioma. Oncogene 11:2145-2149.
22. Park SH, Maeda T, Mohapatra G, Waldman FM, Davis RL, Feuerstein BG (1995): Heterogeneity, polyploidy, aneusomy, and 9p deletion in human glioblastoma multiforme. Cancer Genet Cytogenet 83:127-135.
23. Albarosa R, Colombo BM, Roz L, Magnani I, Polio B, Cirenei N, Giani C, Conti AM, DiDonato S, Finocchiaro G (1996): Deletion mapping of gliomas suggest the presence of two small regions for candidate tumor-suppressor genes in a 17-cM interval on chromosome 10q. Am J Human Genet 58:1260-1267.
24. Rasheed BK, McLendon RE, Friedman HS, Friedman AH, Fuchs HE, Bigner DD, Bigner SH (1995): Chromosome 10 deletion mapping in human gliomas: a common deletion region in 10q25. Oncogene 10:2243-2246.
25. Ye Z, Qu JK, Darras BT (1993): Loss of heterozygosity for alleles on chromosome 10 in human brain tumours. Neurol Res 15:59-62.
26. Campomenosi P, Ottaggio L, Moro G, Urbini S, Bogliolo M, Zunino A, Camoriano A, Inga A, Gentile SL, Pellegata NS, Bonassi S, Bruzzone E, Iannone R, Pisani R, Menichini P, Ranzani GN, Bonatti S, Abbondandolo A, Fronza G (1996): Study on aneuploidy and p53 mutations in astrocytomas. Cancer Genet Cytogenet 88:95-102.
27. Anker L, Ohgaki H, Ludeke BI, Herrman HD, Kleihues P, Westphal M (1993): p53 protein accumulation and gene mutations in human glioma cell lines. Cancer 55:982-987.
28. Henn W, Blin N, Zang KD (1986): Polysomy of chromosome 7 is correlated with overexpression of the erbB oncogene in human glioblastoma cell lines. Hum Genet 74:104-106.
29. Shapiro JR, Shapiro WR (1992): Therapy modifies cellular heterogeneity in human malignant gliomas. Adv Oncol 8:21-29.
30. Bardi G, Johansson B, Pandis N, Heim S, Mandahl N, Hagerstrand I, Holmin T, Andren-Sandberg A, Mitelman F (1992): Trisomy 7 in nonneoplastic focal steatosis of the liver. Cancer Genet Cytogenet 63:22-24.
31. Emanuel A, Szucs S, Weier HU, Kovacs G (1992): Clonal aberrations of chromosomes X, Y, 7 and 10 in normal kidney tissue of patients with renal cell tumors. Genes Chromosom Cancer 4:75-77.
32. Bocchini V, Casalone R, Collini P, Rebel G, Lo Curto F (1991): Changes in glial fibrillary acidic protein and karyotype during culturing of two cell lines established from human glioblastoma multiforme. Cell Tissue Res 265:73-81.
33. Jones TR, Bigner SH, Schold SC, Eng LF, Bigner DD (1981): Anaplastic human gliomas grown in atymic mice: morphology and glial fibrillary acidic protein expression. Am J Pathol 105:316-327.
34. Lichtenberg FV (1989): Robins Pathologic Basis of Disease. Saunders, Philadelphia.
35. Lipsky RH, Silverman SJ (1987): Effects of mycophenolic acid on detection of glial filaments in human and rat astrocytoma cultures. Cancer Res 47:4900-4904.
36. Maunoury R (1977): Establishment and characterization of 5 human cell lines derived from a series of 50 primary intracranial tumors. Acta Neuropathol (Berlin) 39:33-41.
37. Osborne M, Weber K (1983): Tumor diagnosis by intermediate filament typing: a novel tool for surgical pathology. Lab Invest 48:372-394.
38. 2 inhibits the generation of lymphokine-activated killer (LAK) cells. Int J Cancer 42:562-567.